CXCL12 and ischemia: ESWT also promotes tissue regeneration and improves ischemia-related organ dysfunction, mainly by enhancing angiogenesis, upregulating the expression of stromal cell-derived factor (SDF)-1α, recruiting endothelial progenitor cells, suppressing inflammation, and generating oxidative stress [99,100,101].